His research focuses on understanding the determinants for the pharmacokinetics (PK) and pharmacodynamics (PD) of ADCs. His lab uses the principles of PK/PD Modeling & Simulation to support discovery and clinical translation of novel ADCs. Some current research projects is lab include: quantifying bystander effect of ADCs, understanding the determinants for the elimination of high DAR ADCs, evaluating the effect of antigen expression on intracellular ADC PK, and development of a platform PBPK model for ADCs.